Structure and function in engineered lung surfactant peptides

被引：0
|
作者：
Kurutz, JW
Gopal, A
Jiarpinitnun, C
Lau, B
Ege, C
Wu, GH
Majewski, J
Kjaer, K
Waring, AJ
Lee, KYC
机构：
[1] Univ Chicago, Dept Chem, Inst Biophys Dynam, Chicago, IL 60637 USA
[2] James Franck Inst, Chicago, IL 60637 USA
[3] Los Alamos Natl Lab, Manuel Lujan Jr Neutron Scattering Ctr, Los Alamos, NM 87545 USA
[4] Riso Natl Lab, Dept Phys, DK-4000 Roskilde, Denmark
[5] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA
来源：
BIOPHYSICAL JOURNAL | 2003年 / 84卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：310A / 310A
页数：1
相关论文
共 50 条
  • [21] Molecular association and function of calf lung surfactant
    Martinez Montano, Maria del Lurdez Consuelo
    Munoz Sanchez, Jose Luis
    Baeza Ramirez, Isabel
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2007, 41 (02): : 237 - 245
  • [22] ANTI-ATELECTATIC FUNCTION OF LUNG SURFACTANT
    PETROV, OV
    FILIPPENKO, LN
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1981, 91 (04) : 438 - 441
  • [23] The Role of Domains and Proteins in the Function of Lung Surfactant
    Baoukina, Svetlana
    Tieleman, D. Peter
    BIOPHYSICAL JOURNAL, 2011, 100 (03) : 640 - 640
  • [24] METABOLIC FACTORS AFFECTING LUNG SURFACTANT FUNCTION
    KATZ, P
    GAIL, D
    GROSS, H
    MASSARO, DJ
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1971, 103 (06): : 905 - &
  • [25] Secondary structure in lung surfactant SP-B peptides:: IR and CD studies of bulk and monolayer phases
    Dieudonné, D
    Mendelsohn, R
    Farid, RS
    Flach, CR
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2001, 1511 (01): : 99 - 112
  • [26] STRUCTURE AND FUNCTION OF PULMONARY SURFACTANT PROTEINS
    WEAVER, TE
    WHITSETT, JA
    SEMINARS IN PERINATOLOGY, 1988, 12 (03) : 213 - 220
  • [27] Surfactant protein B: Structure and function
    Hawgood, S
    BIOLOGY OF THE NEONATE, 2004, 85 (04): : 285 - 289
  • [28] The structure and function of surfactant protein-A
    McCormack, F
    CHEST, 1997, 111 (06) : S114 - S119
  • [29] An adverse outcome pathway for lung surfactant function inhibition leading to decreased lung function
    Da Silva, Emilie
    Vogel, Ulla
    Hougaard, Karin S.
    Perez-Gil, Jesus
    Zuo, Yi Y.
    Sorli, Jorid B.
    CURRENT RESEARCH IN TOXICOLOGY, 2021, 2 : 225 - 236
  • [30] Altered phospholipid composition and aggregate structure of lung surfactant is associated with impaired lung function in young children with respiratory infections
    Mander, A
    Langton-Hewer, S
    Bernhard, W
    Warner, JO
    Postle, AD
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2002, 27 (06) : 714 - 721
12345